Canada Pet Nutraceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The canada pet nutraceuticals market was valued at USD 162.33 million in 2025 and is projected to grow from USD 176.92 million in 2026 to USD 275.98 million by 2031, registering a CAGR of 9.28% during the forecast period (2026-2031). This report is Segmented by Sub-Product (Milk Bioactives, Omega-3 Fatty Acids, Probiotics, Proteins and Peptides, Vitamins and Minerals, and More), by Pets (Cats, Dogs, and Other Pets), and by Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets and Hypermarkets, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).

Canada Pet Nutraceuticals Market Trends and Insights

Pet Humanization and Preventive Health Spending

The rising trend of pet humanization and an increasing focus on preventive healthcare, as pet owners are investing in wellness-oriented products to address potential health issues before they become severe. According to the 2024 Canadian Pet Population Survey, published in March 2025, dogs visited veterinarians an average of twice per year, while cats visited veterinarians once per year. This data underscores the strong commitment of pet owners to routine healthcare and professional wellness advice. Frequent veterinary visits have contributed to the growing adoption of nutraceutical products, including probiotics, joint-support supplements, omega-3 formulations, and digestive health solutions, as pet owners prioritize their pets' long-term health and quality of life.

Aging Pet Population and Chronic Condition Management

The growing awareness of age-related health issues in companion animals and the increasing adoption of preventive wellness solutions for senior pets are driving the demand for pet nutraceutical products. Guidance from Veterinary Centers of America (VCA) Canada Animal Hospitals highlights that aging dogs and cats may face reduced nutrient absorption due to metabolic changes and weakened immune systems, making them more prone to infections. As a result, pet owners are incorporating nutraceutical products such as omega fatty acids, probiotics, digestive enzymes, glucosamine, coenzyme Q-10, and L-carnitine into their pets' daily care routines. These products promote healthy aging, mobility, digestive health, and overall quality of life, thereby contributing to the growth of the industry.

Limited Clinical Differentiation Across Many Supplement Claims

The lack of significant clinical differentiation among many pet nutraceutical formulations remains a challenge for industry growth. In Canada, pet supplements are primarily marketed as Veterinary Health Products (VHPs), a classification established by Health Canada for low-risk products aimed at maintaining or promoting animal health and welfare, rather than diagnosing, treating, curing, or preventing diseases. Consequently, products in categories such as joint health, digestive health, immune support, and healthy aging often feature similar wellness-oriented claims. This similarity makes it challenging for pet owners and veterinarians to evaluate products based on clinically validated efficacy. Furthermore, the absence of pharmaceutical-level efficacy requirements for many supplement categories undermines confidence in performance claims, complicates product comparisons, and hinders the adoption of premium nutraceutical formulations, thereby restricting industry growth.

Other drivers and restraints analyzed in the detailed report include:

• Veterinary Endorsement of Functional Ingredients
• Premiumization of Health-Positioned Pet Nutrition
• Ingredient Sourcing Volatility for Marine and Specialty Actives

Segment Analysis

The Canada pet nutraceuticals market share for vitamins and minerals accounted for 25.6% in 2025, the largest share within the market. Vitamins and minerals maintain their leading position due to their ability to address a wide range of wellness needs across various pet life stages and health conditions. Their versatility enables their inclusion in formats such as soft chews, powders, liquids, tablets, and food toppers, contributing to broad consumer acceptance. Manufacturers continue to develop formulations targeting immune health, skin and coat care, bone strength, and healthy aging. Compatibility with routine feeding practices and preventive care strategies further drives sustained demand for these products within the companion animal nutrition market.

Vitamins and minerals are projected to grow at the fastest CAGR of 9.8% from 2026 to 2031. This growth is driven by an increasing preference for targeted micronutrient supplementation over general wellness blends. Pet owners are prioritizing products designed for specific outcomes, such as cognitive support, digestive health, mobility enhancement, and immune system resilience. Veterinary recommendations continue to endorse the use of condition-specific vitamin and mineral products as part of preventive care programs. Manufacturers are addressing this demand by improving ingredient quality, enhancing palatability, and offering convenient delivery formats, ensuring the segment remains competitive within the expanding pet nutraceutical market.

Complete Report Scope:

• By Sub Product
  • Milk Bioactives
  • Omega-3 Fatty Acids
  • Probiotics
  • Proteins and Peptides
  • Vitamins and Minerals
  • Other Nutraceuticals
• By Pets
  • Cats
  • Dogs
  • Other Pets
• By Distribution Channel
  • Convenience Stores
  • Online Channel
  • Specialty Stores
  • Supermarkets/Hypermarkets
  • Other Channels

List of Companies Covered in this Report:

• Nestlé S.A.
• Mars, Incorporated
• Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company)
• The J. M. Smucker Company
• Zoetis Inc.
• Elanco Animal Health Incorporated
• Virbac S.A.
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• General Mills, Inc.
• Petcurean Pet Nutrition Inc.
• Rolf C. Hagen Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support